Skip to content
GullySales

API manufacturers · Lead generation

Find the formulators who buy your molecule and start a trial with them.

Lead generation for an API plant means identifying the sourcing, R&D and quality teams that use your molecule and giving them a reason to request a sample. GullySales works on the buyer list, the molecule pages and the record that shows where each enquiry came from.

Scope, fee, reporting and term are agreed in writing after we have read your brief and spoken to you.

Pharmaceutical staff inspect sealed medicine packs in a cleanroom

What lead generation means

Lead generation is the combined work of every channel that brings in a new enquiry, whether from search, adverts, referrals or a stall at an exhibition. GullySales runs these channels together and reports the number of enquiries each one produced, not the activity behind it.

Plan the next part of the work

Last updated 21 Nov 2026.

For API manufacturers

Where it usually goes wrong, and what we would do.

  • “A lead here is a company that uses the molecule”

    A visitor who asks for a quotation on a molecule you do not make is noise. A formulator that already buys the molecule from someone else is a lead. The list is built from molecules outwards, so every name on it has a reason to talk to you.

  • “The person who enquires is rarely the person who decides”

    A purchase executive sends the first mail, while the quality head and R&D decide whether the source is worth qualifying. Lead records that hold only one name lose the other two, and the follow-up then goes to the wrong desk.

  • “Traders answer first and hide the end buyer”

    A trader asking for a price may be quoting for a formulator you could serve directly. Asking who the material is for, politely and early, tells you whether the enquiry is a lead or a quotation request on behalf of someone else.

  • “A sample request is the real conversion”

    A contact form filled in means little. A request for a sample lot with a document pack means a trial is possible, so the form, the page and the log are all built around that one request.

What we do

What we deliver for API manufacturers.

The work available for this need. We agree the deliverables and responsibilities for your engagement in writing.

  1. A molecule-by-molecule buyer list

    Formulators and contract manufacturers who use each molecule you make, with the known source and the roles to approach.

    Result: Open any molecule and read the companies on its list and who at each company to write to.

  2. An enquiry form built for sample requests

    Fields for molecule, grade, intended dosage form and the company the material is for, instead of a general contact box.

    Result: Each enquiry arrives with grade, use and end company filled in.

  3. A source tag on every lead

    A record of whether the lead came from search, a trade event, an introduction or outreach.

    Result: You can list the leads that came from each route and read what happened to them.

  4. A trader screen

    One or two polite questions that ask which formulator the material is for and in which market.

    Result: Each trader enquiry is marked as a direct buyer, a trader with a named end buyer, or a price check.

  5. Hand-off notes to your sales head

    A short summary of each qualified lead with the roles involved and the documents already sent.

    Result: Your sales head opens a lead and sees what has been said and what is outstanding.

How the result is measured

  • Relevant enquiries by source
  • Duplicate and unsuitable enquiries
  • Time to the first response
  • Accepted enquiries reaching an agreed next step

Recorded as a baseline before work starts, so every later report has an honest comparison.

What to capture or send

Record these facts when a molecule enquiry arrives.

Molecule, grade and pharmacopoeial standard
The person who receives the enquiry notes it, so a request for something you do not make is separated from one you do.
Intended dosage form
Asked on the form. Tablet, injectable and oral liquid buyers want different documents and different questions answered first.
Company the material is for
A trader is asked politely who the end buyer is. The answer marks the enquiry as direct, trader-held or a price check.
Roles in contact at the buyer
Purchase, R&D, quality or regulatory. Sales records every name, so the follow-up reaches the person who decides.
Current source of the molecule
Noted if the buyer will say. It shows whether you are replacing a supplier or adding a second source.

Who it is for

This is written for these API manufacturers.

  • Generic API manufacturers for domestic formulators
  • Regulated-market API plants with overseas filings
  • Intermediate and advanced intermediate producers
  • Herbal extract and phytochemical API makers
  • Vitamin, amino acid and nutraceutical ingredient producers
  • Veterinary API manufacturers
  • Peptide and complex molecule producers
  • Custom synthesis and CDMO units making APIs to order

Before you decide

When this may not be the right fit.

  • Your regulatory and quality teams have not agreed what documents may be sent to a new buyer, so a sample request would stall at the first reply.
  • You cannot supply the grade a buyer asks for, and more enquiries on it would only produce refusals.

Before you decide

Agree the work. Know how to judge it.

Lead generation for API manufacturers: use these checks to prepare, choose the scope, and review what changes.

Bring the right evidence

Define the organisations or buyers you can serve and the reasons they would consider a conversation. Bring examples of accepted and rejected prospects so the selection rule is visible.

Make the scope clear

Agree the research sources, contact approach, qualification rules, and handover. Clarify which meetings count as accepted and what happens to replies that are not ready to buy.

Check the work in use

Review why a prospect was selected and what was learned from the response. Count held, relevant conversations separately from contacts found, messages sent, or meetings booked.

Know when to change course

If the same objection appears repeatedly, adjust the offer or buyer group before increasing outreach. Respect a request to stop contact and keep the exclusion in the record.

These are discussion points, not a fixed package. GullySales confirms the deliverables, responsibilities, fee, and term in writing after reading your brief and speaking with you.

Before we start

What to have ready before the work starts.

The records, access and decisions this work needs from API manufacturers. Anything missing is noted in the written scope, with who will supply it.

The sample dispatch register
Bring the register or sheet showing which buyers received samples of which molecule, and when. We use it to see where sample requests really came from. Without it, the baseline rests on memory, and later comparison is weaker than it should be.
A named person for each molecule enquiry
Someone in sales must own replies for each molecule or group. We route the form to that person. If ownership is vague, enquiries land with whoever is free, and the trader screen is applied unevenly. Put a name against each molecule or group of molecules.
Approved product documents list
List the certificate of analysis format, the specification sheets and any filing references your regulatory staff approve for sending. The form and the replies point to these. A missing approval means that document is left out of the first reply.
A decision on who may receive a sample
Your management must say which buyer types may receive a sample, and under what conditions. We build the trader screen on that rule. Without a decision, every sample request becomes a case-by-case argument. Even a short written rule, signed by management, is better than a verbal one.
Trade event and directory subscription details
Bring the list of events attended and directories paid for, with the account logins held by the company. We tag enquiries from each. If a listing is held in an ex-employee's name, we flag it for transfer. Renewal dates help us judge which listing to keep.

How it works

How the lead generation work runs

The work itself, in order. How an engagement starts, from your brief to a written scope, is set out on our method page.

  1. 1

    List molecules by who actually buys them

    We sit with your sales head and go through each molecule you make, naming the formulators, contract manufacturers and traders who have asked for it. You mark which names are real users and which are only brokers, and we keep that list as the base.

  2. 2

    Read old enquiries for the sample requests

    We open the enquiry mails, call notes and trade-event cards from the past seasons and pick out the ones that asked for a sample. You tell us which of those became trials, so we learn which signals are real. We mark each one with the molecule and the company.

  3. 3

    Rebuild the enquiry form around the sample

    We replace the generic contact form with one asking molecule, grade, quantity, company type and the document wanted. Your regulatory staff review the fields, and anything that sounds like a claim about the product is removed before the form is used. Fields that only add friction are dropped.

  4. 4

    Tag every enquiry with its source

    We agree a short list of source names, such as directory, website, trade event, referral and trader, and add a required field in your enquiry record. Your sales team tests it on live enquiries, and we simplify any entry that slows a reply. Refusals are worded so that the door stays open for a real formulator.

  5. 5

    Screen the traders before the plant visit

    We write the two or three questions your sales head asks a trader who requests a sample, to learn the end buyer and the intended use. You decide which answers lead to a sample and which lead to a polite refusal.

  6. 6

    Compare enquiry sources with the start record

    When enough enquiries exist, we read the source tags against the figures noted at the start: sample requests, trials begun and purchase orders. You see which source brought buyers who actually tested, and your sales head decides where to look further.

Where this fits

Three pieces of sales work, in this order.

This work sits inside sales process design, at stage 1, prospecting and lead generation. The audit comes before it, and sales management keeps it running.

  1. Step 1

    Sales audit

    Find where deals are being lost and what to fix first.

    Start here if you cannot say where orders are lost.

  2. Step 2 · you are here

    Sales process design

    One written way to sell, from first enquiry to repeat order.

    Start here if every salesperson sells differently.

  3. Step 3

    Sales management

    A target, a review routine and someone who owns the number.

    Start here if the team has targets and no routine.

Tell us what you need Your brief is read before we call. Scope, fee and term in writing.

FAQ

Questions owners ask before they call.

Not here? More answers, or ask on WhatsApp.

Should we chase every enquiry for a molecule we make?
Not with the same effort. Mark each as a direct formulator, a contract manufacturer, a trader or an importer, then give the first two the fullest reply. The others still get a prompt answer, with less custom work behind it.
Can we buy a list of pharma buyers?
A bought list gives names without context. A list built by molecule shows who uses what you make, so each message can speak about a grade or a use. Check that any list you use was gathered in a way you are comfortable with.
Does lead generation mean we change our regulatory statements?
No. Every statement stays exactly as your regulatory team has cleared it. Advertising rules differ by profession and state, so check with your own regulatory adviser before anything new goes public.
How do we treat an overseas importer who asks for a sample?
Ask for the intended market and the registration plan before sending anything. Rules differ by country, and your regulatory team should check what the buyer can import. An enquiry with no plan is a quotation request, not a trial.
How do we tell a real formulator from a broker posing as one?
Ask for the intended product, the dosage form and the manufacturing site before sending a sample. A formulator names a product and a plant; a broker avoids both. Your sales head decides how much to share with a broker, and the answer to each question is recorded against the enquiry so the next call is easier. Put the three questions to every new enquirer in the same words, so that the pattern can be seen later and nobody is accused of treating a buyer unfairly.
Who writes to the buyers we find through the list?
Your sales head or technical sales staff write the first message, because the buyer expects a reply from someone who can answer a technical question. We draft the wording and the molecule pages that the message points to, and your regulatory team clears every statement before it is sent to anyone. The first message also introduces the molecule page, so the buyer can look at the specification before replying, and the follow-up record notes which page was sent.
How much does it cost?
There is no price list, because the work differs by business. The fee is scoped after we have read your brief and spoken to you, and put in writing before anything starts, split into our time, your media spend and production.
How long is the contract?
The term is agreed in writing after we have spoken, along with the fee and the reporting. It is never a default twelve months, and renewal is decided on the numbers against the baseline recorded at the start.
How soon will we see results?
It depends on the trade, the channel and what is already in place. After we have read your brief and spoken to you, we say what we would expect to move first and how it will be measured against the baseline. Nothing here is guaranteed.
Who will actually do the work?
The person you speak to before anything starts. We work from one office in Nagarbhavi, Bengaluru, with no account managers in between.

Your next practical step

Tell us what you are trying to grow, and we will read it before we call.

Eight short steps, mostly taps. Skip anything you would rather answer on the call.